Medical articles today

/* 728x15, */

Medium Term Outcome Of Laparoscopic Sacrocolpopexy With Xenografts Compared To Synthetic Grafts

UroToday.com - Graft materials are increasingly being used to improve surgeries for pelvic floor prolapse, in an effort to reduce recurrence. There is some evidence this is indeed so, but a number of graft related complications (GRC) cause clinically relevant problems (erosion, pain, dyspareunea) and may lead to reintervention. This may be the consequence of an inappropriately balanced response of the host to the implant. One potentially causative factor for GRC is the choice of implant material. The most widely used product today is polypropylene, in an open construct with pores large enough to allow in growth of tissue by the host. As an alternative "biologic" matrices have been proposed.

Fresenius Medical Care Sends Dialysis Supplies For Haiti Relief Effort

Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach those in need following a devastating earthquake and aftershock. FMCNA is shipping four dialysis machines and 10, 000 pounds of supplies this week to a private port in Haiti, in conjunction with the company Dialysis at Sea, which provides dialysis on cruise ships. The supplies will be distributed as they are needed. This is the second shipment FMCNA has sent for Haiti relief efforts.

/* 468x60, */

Kidney-Disease Drug With Dartmouth Origins Licensed In Asia

Thanks in part to more than a decade of preclinical work by Dartmouth researchers, a Japanese biopharmaceutical firm is preparing to develop and market throughout Asia a drug for the treatment of chronic kidney disease (CKD). In a deal worth $272 million plus royalties, the firm Kyowa Hakko Kirin bought exclusive rights to the compound bardoxolone methyl - or CDDO-methyl ester (CDDO-Me), in the scientific literature - from Texas-based Reata Pharmaceuticals on Thursday, January 7. The drug belongs to a family of anti-inflammatory compounds called triterpenoids, which chemist Tadashi Honda, Ph.D., began synthesizing at the Dartmouth laboratory of Gordon Gribble, Ph.

Georgia's Kidney Care Community Praises Introduction Of Legislation To Improve Patient Access To Quality Kidney Dialysis And Transplant Care

Members of Georgia's kidney care community - including patients, physicians, providers, and kidney transplant groups - today applauded State Senators Don Thomas (R-Dalton) and Ed Harbison (D-Columbus) for introducing bipartisan legislation to help approximately 2, 000 Georgians suffering from kidney failure who are having difficulty accessing health insurance for their dialysis care or needed transplant medications. If enacted, this legislation could result in a positive fiscal impact of approximately $20 million over five years for Georgia's Medicaid system. In addition to helping people with kidney failure, the legislation will also help any Georgia citizen who is under 65 and has Medicare as a result of a disability.

Implantation Of Erectile Prosthesis Is Complicated: European Urology February Issue

The final step in the multidisciplinary approach of gender reassignment therapy in female-to-male transsexuals consists of the construction of a neophallus to allow the patient to void while standing and to have sexual experience after he is accustomed to his new voiding abilities. The main limiting factor is that there is no good substitute for the unique erectile tissue of the penis. The largest retrospective study by Hoebeke et al. evaluates the outcome in 129 female-to-male transsexuals after implantation of a hydraulic erectile prosthesis. The article is the largest retrospective study of female-to-male transsexuals with implantation of inflatable prosthesis into neophallus.

/* 468x60, */

Use Of Traditional Chinese Medicine In The Management Of Urinary Stone Disease

UroToday.com - As we reviewed the best level of evidence concerning the use of Chinese medicine in urinary stone disease in the English language Literature to accomplish this paper, we also faced the barrier imposed by the lack of knowledge of other languages such as Mandarim or Japanese. Had we been able to extend our research to these Asian manuscripts we might have found additional information to shed some more light on this mostly interesting but still not fully explored field. This review also puts in evidence the fact that when dealing with concepts of diagnosis or treatment that are not universally accepted, the scientific methods may be compromised.

/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy